News

Patient Zero Detection®: Retarus granted Europe-wide patent

The European Patent Office has granted Retarus a Europe-wide patent for the Patient Zero Detection® technology developed by the company. The innovative approach to analyzing and recognizing harmful emails is an integral component of the comprehensive E-Mail Security Services offered by the global information logistics provider. Patient Zero Detection® swiftly identifies recipients of new,...

Read more

Tags: //

News Security

Retarus enlarges its patent firepower

In mid-November we were granted another patent, this time by the European Patent Office (EPO). It bears the number EP3297221 and describes a “Technique For Detecting Suspicious Electronic Messages”. In concrete terms, the patent is about detecting electronic messages, such as emails, which are highly likely to have been sent in large volumes by means of a botnet. To explain how this works in a...

Read more

Tags: // //

News

We have just received our first US patent

The United States Patent and Trademark Office (USPTO) recently granted us our first US patent – and of course we’re mighty proud of the achievement! Good things do indeed come to those who wait – we had already submitted the patent specification document in early February 2016.Then on August 21st, 2018, our application became patent number 10,057,454 B2. It describes a “METHOD FOR TRANSMITTING...

Read more

Tags: //